LeMaitre Vascular Inc (LMAT) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

Total Revenue Chart for LeMaitre Vascular Inc

LeMaitre Vascular Inc (LMAT) revenue for FY2025 was USD 249.6M, a 13.5% change from FY2024. LeMaitre Vascular Inc's revenue grew from USD 12.6M in 2001 to USD 249.6M in 2025 (1888.9% over 24 years). Earnings per share grew from USD 0.11 in 2004 to USD 0.93 in 2022 (738.8%). Revenue compound annual growth rate: 5-year CAGR of 14.0%, 10-year CAGR of 12.3%, 20-year CAGR of 11.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.85B
Implied Share Price
$80.82
Enterprise Value
$1.66B
Revenue (TTM)
$262.43M
EBITDA
$83.02M
Profit Margin
25.02%
Trailing P/E
28.36
Forward P/E
25.58
Price/Book (MRQ)
4.38
Price/Sales (TTM)
7.04
EV/EBITDA
16.49
EV/Revenue
6.31
Dividend Yield
1.08%
Book Value
$18.38
Free Cash Flow (FY2025)
$74.47M
Free Cash Flow Yield
4.03%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.